Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 10, 2020 07:00 ET | Source: Aleafia Health Inc.

Aleafia Health to Enter Israeli Cannabis Market, Bolstering International Sales Opportunity

Three-year agreement signed with Equinox InternationalShipments expected to commence in Q1 2021, marking Aleafia’s fourth country with products in marketIsrael is largest net importer of medical...
December 06, 2020 13:00 ET | Source: MacroGenics, Inc.

MacroGenics Presents Flotetuzumab Data in Patients with Refractory Acute Myeloid Leukemia at the 2020 ASH Annual Meeting

31.8% CR/CRh/CRi rate in primary induction failure and early relapsed AML patientsMedian duration of response = 8.13 months ROCKVILLE, MD, Dec. 06, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc....
December 02, 2020 07:00 ET | Source: Sio Gene Therapies

Sio Gene Therapies Announces First Patient Dosed in High-Dose Cohort of AXO-AAV-GM1 Clinical Trial in Patients with GM1 Gangliosidosis

On-track to report topline results from low-dose cohort by end of 2020 NEW YORK and RESEARCH TRIANGLE PARK, N.C., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (NASDAQ: SIOX), a...
November 11, 2020 07:30 ET | Source: Aleafia Health Inc.

Aleafia Health Announces Third Quarter 2020 Results

TORONTO, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) is pleased to report its financial results for the three and nine months...
November 05, 2020 10:13 ET | Source: Agritek Holdings, Inc.

Agritek Holdings, Inc. Announces Agreement Between Subsidiary Full Spectrum Biosciences Inc. and California Based Biomedican, to Produce First Yeast Based Cannabinoid Compounds

Synthetic CBG Nutraceutical Products in New Test Pilot Program LOS ANGELES, CA, Nov. 05, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Agritek Holdings, Inc. (AGTK) (www.AgritekHoldings.com), a...
November 04, 2020 16:01 ET | Source: MacroGenics, Inc.

MacroGenics Provides Update on Corporate Progress and Third Quarter 2020 Financial Results

ROCKVILLE, Md., Nov. 04, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
October 27, 2020 09:00 ET | Source: The Battery Show

The Battery Show & EV Tech Digital Days Announces Virtual Product Showcase Lineup Featuring 17 Technologies and Solutions from the Industry’s Top Suppliers

SANTA MONICA, Calif., Oct. 27, 2020 (GLOBE NEWSWIRE) -- The Battery Show & EV Tech Digital Days, an all-new virtual event connecting the global advanced battery and EV/HEV tech community taking...
September 22, 2020 16:30 ET | Source: MacroGenics, Inc.

MacroGenics Announces Publication of Flotetuzumab Interim Phase 1/2 Clinical Trial Results in Blood

ROCKVILLE, MD, Sept. 22, 2020 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
September 20, 2020 09:10 ET | Source: MacroGenics, Inc.

MacroGenics Announces Presentation of MGD019 Phase 1 Data at the ESMO Virtual Congress 2020

MGD019 well-tolerated with early signals of activity in advanced solid tumors not typically responsive to checkpoint inhibitionRecommended Phase 2 dose established for MSS CRC, NSCLC expansion...
August 26, 2020 17:00 ET | Source: The Flowr Corporation

The Flowr Corporation Announces Second Quarter 2020 Results

TORONTO, Aug. 26, 2020 (GLOBE NEWSWIRE) -- The Flowr Corporation (TSX.V: FLWR; OTC: FLWPF) (“Flowr” or the “Company”) herein announces its financial and operational results for the second quarter...